aa 861 has been researched along with Shock, Septic in 3 studies
2,3,5-trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone: structure given in first source
docebenone : A member of the class of benzoquinones that is p-benzoquinone in which the hydrogens are substituted by three methyl groups and a 12-hydroxydodeca-5,10-diyn-1-yl group.
Shock, Septic: Sepsis associated with HYPOTENSION or hypoperfusion despite adequate fluid resuscitation. Perfusion abnormalities may include but are not limited to LACTIC ACIDOSIS; OLIGURIA; or acute alteration in mental status.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To elucidate the effect of arachidonic acid metabolite inhibitors on liver injury in endotoxin shock with special reference to the role of polymorphonuclear leukocytes (PMNs), we pretreated rats with three kinds of arachidonic acid metabolite inhibitors (hydrocortisone, Hy; AA-861, AA; indomethacin, In) in our rat model of endotoxin shock." | 7.69 | [The effect of arachidonic acid metabolite inhibitors on liver injury in endotoxin shock, with special reference to the role of polymorphonuclear leukocytes (PMNs)]. ( Furukawa, K; Kobayashi, T; Onda, M, 1994) |
| "To elucidate the effect of arachidonic acid metabolite inhibitors on liver injury in endotoxin shock with special reference to the role of polymorphonuclear leukocytes (PMNs), we pretreated rats with three kinds of arachidonic acid metabolite inhibitors (hydrocortisone, Hy; AA-861, AA; indomethacin, In) in our rat model of endotoxin shock." | 3.69 | [The effect of arachidonic acid metabolite inhibitors on liver injury in endotoxin shock, with special reference to the role of polymorphonuclear leukocytes (PMNs)]. ( Furukawa, K; Kobayashi, T; Onda, M, 1994) |
| "Specific treatments in septic shock should be instituted administration of glucocorticoid, antibiotics, protease inhibitor and lipoxygenase inhibitor." | 1.28 | [Effects of anti-toxic agents in septic shock]. ( Asaishi, K; Ebata, T; Hasegawa, I; Hayasaka, H; Hiraike, N; Minamida, H; Yamamoto, Y, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kobayashi, T | 1 |
| Furukawa, K | 1 |
| Onda, M | 1 |
| Shiba, T | 1 |
| Ikeda, M | 1 |
| Hara, A | 1 |
| Yoshida, H | 1 |
| Kaneko, H | 1 |
| Takeuchi, S | 1 |
| Ebata, T | 1 |
| Asaishi, K | 1 |
| Hiraike, N | 1 |
| Yamamoto, Y | 1 |
| Hasegawa, I | 1 |
| Minamida, H | 1 |
| Hayasaka, H | 1 |
3 other studies available for aa 861 and Shock, Septic
| Article | Year |
|---|---|
[The effect of arachidonic acid metabolite inhibitors on liver injury in endotoxin shock, with special reference to the role of polymorphonuclear leukocytes (PMNs)].
Topics: Animals; Arachidonic Acid; Benzoquinones; Hydrocortisone; Indomethacin; Liver Diseases; Male; Neutro | 1994 |
Mechanism of acute gastrointestinal mucosal damage in endotoxic shock and the effect of Fragmin.
Topics: Acute Disease; Animals; Benzoquinones; Dogs; Gastric Mucosa; Hemorrhage; Heparin; Heparin, Low-Molec | 1990 |
[Effects of anti-toxic agents in septic shock].
Topics: Animals; Benzamidines; Benzoquinones; Dexamethasone; Fibrin Fibrinogen Degradation Products; Guanidi | 1989 |